Home/Filings/4/0001181431-05-033421
4//SEC Filing

CLOSURE MEDICAL CORP 4

Accession 0001181431-05-033421

CIK 0001016006operating

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 3:13 PM ET

Size

14.3 KB

Accession

0001181431-05-033421

Insider Transaction Report

Form 4
Period: 2005-06-03
SCHMIDT ROLF D
Director10% Owner
Transactions
  • Disposition to Issuer

    Common Stock

    2005-06-03$27.00/sh2,907,331$78,497,9370 total
  • Disposition to Issuer

    Non-Employee Director Stock Option (right to buy)

    2005-06-03$5.00/sh10,772$53,8600 total
    Exercise: $22.00Exp: 2007-06-04Common Stock (10,772 underlying)
  • Disposition to Issuer

    Non-Employee Director Stock Option (right to buy)

    2005-06-03$7.00/sh60,000$420,0000 total
    Exercise: $20.00Exp: 2010-06-13Common Stock (60,000 underlying)
  • Disposition to Issuer

    Non-Employee Director Stock Option (right to buy)

    2005-06-03$2.44/sh10,431$25,4520 total
    Exercise: $24.56Exp: 2008-06-03Common Stock (10,431 underlying)
Footnotes (3)
  • [F1]Includes a) 179,974 shares owned directly b) 2,047,445 shares held by Cacossing Partners, L.P., a limited partnership of which Rolf D. Schmidt is the sole general partner c) 539,912 shares held by OMI Partners L.P., a limited partnership of which Rolf D. Schmidt is a general partner and d) 140,000 shares owned jointly by Rolf D. Schmidt and his spouse.
  • [F2]Disposed of pursuant to the merger agreement between Closure Medical Corporation, Johnson & Johnson and Holden Merger Sub, Inc., a wholly owned subsidiary of Johnson & Johnson, in exchange for a cash payment of $27 per share on the effective date of the merger.
  • [F3]This option, which became exercisable with respect to 50% of the shares on the date of grant with the remainder vesting in two equal annual installments commencing on the first anniversary of the date of grant, was canceled in the merger pursuant to the terms of the merger agreement between Closure Medical Corporation, Johnson & Johnson and Holden Merger Sub, Inc., a wholly owned subsidiary of Johnson & Johnson, in exchange for a cash payment equal to the difference between $27 and the exercise price of the option.

Issuer

CLOSURE MEDICAL CORP

CIK 0001016006

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001016006

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 3:13 PM ET
Size
14.3 KB